1h
Hosted on MSNBain Capital buys Mitsubishi Tanabe Pharma for $3.3bnBain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
The Mitsubishi Chemical Group is selling its centuries-old pharmaceutical business to Bain Capital in a carve-out worth about ...
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...
From newcomer Setchu to stalwarts like Junya Watanabe and Comme des Garçons, Japanese designers are commercially and ...
We recently published a list of the Top 12 Luxury Clothing Stocks to Buy According to Hedge Funds. In this article, we are ...
We recently published a list of the Top 12 Luxury Clothing Stocks to Buy According to Hedge Funds. In this article, we are ...
Platforms powered by Zero Hash can now leverage RLUSD for transactionsCHICAGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Zero Hash, the leading cry ...
Capri Holdings forecast revenue for the year as well as fiscal 2026 below Wall Street estimates on Wednesday, as the Michael ...
Manufacturing in the U.S. would help European designer brands skirt a tariff war. Luckily, shoppers don’t seem too attached ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results